May 18, 2021 / 12:00PM GMT
Kennen B. MacKay - RBC Capital Markets, Research Division - MD & Co-Head of US Biotechnology Research
Hi. My name is Kennen MacKay. I'm one of the biotech analysts here at here at RBC, and it's my great pleasure to be kicking off our 2021 Virtual Healthcare Conference with Regeneron Pharmaceuticals. From Regeneron, we have Dr. Neil Stahl, the Executive Vice President of R&D; Jamie Orengo, the Vice President of Research, Allergy and Immunity; and Justin Holko, who heads up Communications and IR.
And Justin, I'll pass it to you, before jumping in, to give some of your prepared statements. Go ahead.
Justin Holko - Regeneron Pharmaceuticals, Inc. - VP of IR
Great. Thank you, Kennen. Before we begin, I'd just like to remind everybody that remarks made on today's webcast will include forward-looking statements about Regeneron, including those related to R&D, in particular. Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in that statement. More
Regeneron Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 18, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers